Advertisement

Annals of Hematology

, Volume 71, Issue 4, pp 181–183 | Cite as

Acquired pure red cell aplasia: a study of six cases

  • F. Gilsanz
  • J. A. Garcia Vela
  • J. A. Vargas
  • J. Ibañez
  • F. Oña
  • J. López
  • M. Roggendorf
Original Article

Abstract

Persistent infection by parvovirus B19 associated with pure red cell aplasia (PRCA) has been documented in immunocompromised patients. Bone marrow failure is associated with conditions in which immune surveillance is impaired, and in these instances occult parvovirus infection may be suspected. In this study we have assessed by serological and molecular methods whether parvovirus B19 infection may be a more frequent cause of PRCA than hitherto suspected and whether it may be present in the absence of a typical bone marrow picture. Six patients with PRCA — two with isolated PRCA and no apparent underlying disease, two with a lymphoproliferative disease, one with thymoma, and one with chronic myelomonocytic leukemia — have been studied. Four of the six patients had overt PCRA and were clearly immunocompromised. Parvovirus B19 was not detected in any of the six patients by PCR analysis and serology investigating the presence of IgM or IgG antibodies. Although parvovirus B19 infection needs to be ruled out in PRCA it represents only one, and probably not the most frequent, etiological factor of PRCA.

Key words

Parvovirus Anemia Aplasia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Belloy M, Morinet F, Blondin G, Courouce AM, Peyrol Y, Vilmur E (1990) Erythroid hypoplasia due to chronic infection with parvovirus B19. N Engl J Med 322:633–634Google Scholar
  2. 2.
    Carstensen H, Ornvold K, Cohen BJ (1989) Human parvovirus B19 infection associated with prolonged erythroblastopenia in a leukemic child. Pediatr Infect Dis J 8:56PubMedGoogle Scholar
  3. 3.
    Coulombel L, Morinet F, Mielot F, Tchernia G (1989) Parvovirus infection, leukemia and immunodeficiency. Lancet 1:101–102PubMedGoogle Scholar
  4. 4.
    Dessypris EN (1991) The biology of pure red cell aplasia. Semin Hematol 28:275–284PubMedGoogle Scholar
  5. 5.
    Frickhofen N, Abkowitz JL, Safford M, Berry M, Antunez-de-Mayolo J, Astrow A (1990) Persistent parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia with AIDS. Ann Intern Med 113:926–933PubMedGoogle Scholar
  6. 6.
    Frickhofen N, Chen ZJ, Young NS, Cohen BJ, Heimpel H, Abkowitz JL (1994) Parvovirus B19 as a cause of acquired chronic pure red cell aplasia. Br J Haematol 87:818–824PubMedGoogle Scholar
  7. 7.
    Harris JW (1992) Parvovirus B19 for the hematologist. Am J Hematol 39:119–130PubMedGoogle Scholar
  8. 8.
    Kurtzman G, Ozawa K, Hanson GR, Cohen B, Oseas R, Young N (1987) Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 317:287–294PubMedGoogle Scholar
  9. 9.
    Kurtzman G, Cohen B, Myers P, Amanullah A, Young N (1988) Persistent parvovirus infection as a cause of severe chronic anemia in children with acute lymphocytic leukemia. Lancet 2:1159–1162PubMedGoogle Scholar
  10. 10.
    Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS (1989) Pure red cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 321:519–523PubMedGoogle Scholar
  11. 11.
    Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese M, Young NS (1989) Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 84:1114–1123PubMedGoogle Scholar
  12. 12.
    Marmont AM (1991) Therapy of pure red cell aplasia. Semin Hematol 28:285–297PubMedGoogle Scholar
  13. 13.
    Mintzer D, Reilly R (1987) Pure red cell aplasia associated with human immunodeficiency virus infection: response to intravenous gammaglobulin. Blood 87:124aGoogle Scholar
  14. 14.
    Schwarz TF, Roggendorf M, Deinhardt F (1988) Human parvovirus B19: Elisa and immunoblot assays. J Virol Methods 20:155–168PubMedGoogle Scholar
  15. 15.
    Schwarz TF, Jäger G, Holzgrave W, Roggendorf M (1992) Diagnosis of human parvovirus B19 by polymerase chain reaction. Scand J Infect Dis 24:691–696PubMedGoogle Scholar
  16. 16.
    Smith MA, Shah NR, Lobel JS, Cera PJ, Gary GW, Anderson LJ (1988) Severe anemia caused by human parvovirus in a leukemia patient on maintenance chemotherapy. Clin Pediatr 27:383–386Google Scholar
  17. 17.
    Young NS (1991) The pathogenesis and pathophysiology of aplastic anemia. In: Hoffman R, Benz JR, Shattil SJ, Furie B, Cohen HJ (eds) Hematology. Basic principles and practice. Churchill Livingstone, New York, pp 122–160Google Scholar
  18. 18.
    Weiland HT, Salimans MM, Fibbe WE, Kluin PM, Cohen BJ (1989) Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant recipient. Br J Haematol 71:300PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • F. Gilsanz
    • 1
  • J. A. Garcia Vela
    • 2
  • J. A. Vargas
    • 3
  • J. Ibañez
    • 1
  • F. Oña
    • 2
  • J. López
    • 4
  • M. Roggendorf
    • 5
  1. 1.Department of Hematology, Hospital 12 de OctubreUniversidad ComplutenseMadridSpain
  2. 2.Department of HematologyHospital Universitario de GetafeMadridSpain
  3. 3.Department of Internal Medicine, Clínica Puerta de HierroUniversidad AutonomaMadridSpain
  4. 4.Department of Hematology, Hospital Ramon y CajalUniversidad de Alcala de HenaresMadridSpain
  5. 5.Institut für Medizinische VirologieUniversitätsklinikumEssenGermany

Personalised recommendations